SE507696C2 - Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd - Google Patents

Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd

Info

Publication number
SE507696C2
SE507696C2 SE9601057A SE9601057A SE507696C2 SE 507696 C2 SE507696 C2 SE 507696C2 SE 9601057 A SE9601057 A SE 9601057A SE 9601057 A SE9601057 A SE 9601057A SE 507696 C2 SE507696 C2 SE 507696C2
Authority
SE
Sweden
Prior art keywords
urea
infant
ammonium compound
mmol
ammonium
Prior art date
Application number
SE9601057A
Other languages
English (en)
Swedish (sv)
Other versions
SE9601057L (sv
SE9601057D0 (sv
Inventor
Lars Wiklund
Original Assignee
Lars Wiklund
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lars Wiklund filed Critical Lars Wiklund
Priority to SE9601057A priority Critical patent/SE507696C2/sv
Publication of SE9601057D0 publication Critical patent/SE9601057D0/xx
Priority to JP9533393A priority patent/JP2000507936A/ja
Priority to PT97914690T priority patent/PT888112E/pt
Priority to US09/142,145 priority patent/US6333055B1/en
Priority to CA002249704A priority patent/CA2249704A1/en
Priority to ES97914690T priority patent/ES2176721T3/es
Priority to AT97914690T priority patent/ATE219935T1/de
Priority to DE69713746T priority patent/DE69713746T2/de
Priority to NZ331185A priority patent/NZ331185A/xx
Priority to PCT/SE1997/000361 priority patent/WO1997034590A1/en
Priority to DK97914690T priority patent/DK0888112T3/da
Priority to EP97914690A priority patent/EP0888112B1/de
Priority to AU21840/97A priority patent/AU722642B2/en
Publication of SE9601057L publication Critical patent/SE9601057L/xx
Publication of SE507696C2 publication Critical patent/SE507696C2/sv
Priority to NO984194A priority patent/NO984194D0/no
Priority to US09/987,558 priority patent/US20030021856A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/02—Ammonia; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S297/00—Chairs and seats
    • Y10S297/08—Inflatable bellows

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
SE9601057A 1996-03-20 1996-03-20 Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd SE507696C2 (sv)

Priority Applications (15)

Application Number Priority Date Filing Date Title
SE9601057A SE507696C2 (sv) 1996-03-20 1996-03-20 Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd
AU21840/97A AU722642B2 (en) 1996-03-20 1997-03-04 New use of ammonium compounds and/or urea
AT97914690T ATE219935T1 (de) 1996-03-20 1997-03-04 Verwendung von ammoniumverbindungen und/oder harnstoff
NZ331185A NZ331185A (en) 1996-03-20 1997-03-04 use of ammonium compounds and/or urea for prophylaxis of sudden infant death syndrome
US09/142,145 US6333055B1 (en) 1996-03-20 1997-03-04 Use of ammonium compounds and/or urea
CA002249704A CA2249704A1 (en) 1996-03-20 1997-03-04 New use of ammonium compounds and/or urea
ES97914690T ES2176721T3 (es) 1996-03-20 1997-03-04 Nuevo uso de compuestos del amonio y/o urea.
JP9533393A JP2000507936A (ja) 1996-03-20 1997-03-04 アンモニウム化合物および／または尿素の新規用途
DE69713746T DE69713746T2 (de) 1996-03-20 1997-03-04 Verwendung von ammoniumverbindungen und/oder harnstoff
PT97914690T PT888112E (pt) 1996-03-20 1997-03-04 Utilizacao inovadora de compostos de amonio e/ou de ureia
PCT/SE1997/000361 WO1997034590A1 (en) 1996-03-20 1997-03-04 New use of ammonium compounds and/or urea
DK97914690T DK0888112T3 (da) 1996-03-20 1997-03-04 Anvendelse af ammoniumforbindelser og/eller urinstof
EP97914690A EP0888112B1 (de) 1996-03-20 1997-03-04 Verwendung von ammoniumverbindungen und/oder harnstoff
NO984194A NO984194D0 (no) 1996-03-20 1998-09-11 Ny anvendelse av ammoniumforbindelser og/eller urea
US09/987,558 US20030021856A1 (en) 1996-03-20 2001-11-15 New use of ammonium compounds and/or urea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9601057A SE507696C2 (sv) 1996-03-20 1996-03-20 Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd

Publications (3)

Publication Number Publication Date
SE9601057D0 SE9601057D0 (sv) 1996-03-20
SE9601057L SE9601057L (sv) 1997-09-21
SE507696C2 true SE507696C2 (sv) 1998-07-06

Family

ID=20401857

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9601057A SE507696C2 (sv) 1996-03-20 1996-03-20 Användning av en fysiologisk ofarlig ammoniumförening och/ eller urea för profylax av plötslig spädbarnsdöd samt sätt att diagnostisera risk för plötslig spädbarnsdöd

Country Status (14)

Country Link
US (2) US6333055B1 (de)
EP (1) EP0888112B1 (de)
JP (1) JP2000507936A (de)
AT (1) ATE219935T1 (de)
AU (1) AU722642B2 (de)
CA (1) CA2249704A1 (de)
DE (1) DE69713746T2 (de)
DK (1) DK0888112T3 (de)
ES (1) ES2176721T3 (de)
NO (1) NO984194D0 (de)
NZ (1) NZ331185A (de)
PT (1) PT888112E (de)
SE (1) SE507696C2 (de)
WO (1) WO1997034590A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9572528B1 (en) 2012-08-06 2017-02-21 Los Angeles Biomedical Research Insitute at Harbor-UCLA Medical Center Monitor for SIDS research and prevention
EP3646739A1 (de) 2018-11-01 2020-05-06 N.V. Nutricia Ernährungszusammensetzung mit harnstoff und nichtverdaulichen oligosacchariden

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668772A (en) * 1984-11-27 1987-05-26 Nestec S.A. Methods for controlling the viscosity of protein hydrolysates
CA1297721C (en) * 1987-01-26 1992-03-24 Shalan A. Al-Mashiki PROCESS FOR LOWERING THE CONCENTRATION OF .beta.-LACTOGLOBULIN IN CHEESE WHEY
US5312839A (en) * 1991-03-05 1994-05-17 Regents Of The University Of California Compounds and method for protection of cells and tissues from irreversible injury due to lactic acidosis
US5169666A (en) * 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
AUPM864894A0 (en) * 1994-10-07 1994-11-03 Borody, Thomas Julius Treatment of bowel-dependent neurological disorders

Also Published As

Publication number Publication date
AU2184097A (en) 1997-10-10
US20030021856A1 (en) 2003-01-30
ES2176721T3 (es) 2002-12-01
SE9601057L (sv) 1997-09-21
PT888112E (pt) 2002-11-29
DK0888112T3 (da) 2002-10-21
DE69713746T2 (de) 2002-11-21
NO984194L (no) 1998-09-11
AU722642B2 (en) 2000-08-10
SE9601057D0 (sv) 1996-03-20
DE69713746D1 (de) 2002-08-08
EP0888112B1 (de) 2002-07-03
EP0888112A1 (de) 1999-01-07
WO1997034590A1 (en) 1997-09-25
JP2000507936A (ja) 2000-06-27
CA2249704A1 (en) 1997-09-25
US6333055B1 (en) 2001-12-25
NZ331185A (en) 2000-05-26
NO984194D0 (no) 1998-09-11
ATE219935T1 (de) 2002-07-15

Similar Documents

Publication Publication Date Title
ES2310417T3 (es) Procedimiento para tratar la insuficiencia renal.
US5340603A (en) Nutritional product for human infants having chronic lung disease
KR20070054739A (ko) 종합 경장 영양 조성물
Levine et al. Physiologic handicaps of the premature infant: I. Their pathogenesis
MX2012007775A (es) Composiciones nutritivas y metodos para utilizar las mismas.
Goyens et al. Copper deficiency in infants with active celiac disease
Prasad Zinc in human nutrition
Blumenkrantz et al. Managing the nutritional concerns of the patient undergoing peritoneal dialysis
Oski et al. Anemia due to inadequate iron sources or poor iron utilization
AU722642B2 (en) New use of ammonium compounds and/or urea
DK1776956T3 (en) An agent for the prevention and / or treatment of calcium deficiency
Brown et al. Understanding blood gas interpretation
Kenny et al. Clinical zinc deficiency during adequate enteral nutrition.
RU2400251C1 (ru) Способ лечения хронической болезни почек в додиализном и диализном периодах и лекарственное средство для его реализации
US20040253320A1 (en) Nutritional supplementation for treating deficiency states in bowel disease
US9277761B2 (en) Nutrition trace element composition
Sager et al. Methemoglobinemia associated with acidosis of probable renal origin
JP3556757B2 (ja) 吸収促進性糖類組成物
Davies Problems of the newborn. Feeding
Scorpio et al. Fluids and Electrolytes
JP4953642B2 (ja) 経口経腸栄養剤の投与前処置液
Martindale et al. OVERVIEW OF METABOLISM
JP5076327B2 (ja) 分岐鎖アミノ酸の心不全適応
Littlewood et al. Nutrition in cystic fibrosis
Carrazza et al. Magnesium metabolism in chronic primary hypomagnesemia

Legal Events

Date Code Title Description
NUG Patent has lapsed